Clinical Trial

Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs

Name: Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs — clinical trial record (NCT07222995)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to examine how different messages about risk of skin cancer can impact the uptake of skin cancer prevention activities.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-10-28; most recent amendment 2026-02-03.

Trial Details

NCT Number	NCT07222995
Lead Sponsor	H. Lee Moffitt Cancer Center and Research Institute Collaborators: National Cancer Institute (NCI)
Conditions	Skin Cancer
Enrollment	2,900 participants
Start Date	2025-10-10
Primary Completion	2030-10-10 (estimated)
Study Completion	2030-10-10 (estimated)
Updated on ClinicalTrials.gov	2026-02-05